Listeria is commonly found in processed and prepared foods and listeriosis is associated with high morbidity and mortality. Preventative measures are well prescribed and monitoring and voluntary recall of contaminated products has resulted in a 44% reduction in the prevalence of perinatal listeriosis in the USA. Pregnant women are at high risk for listeriosis, but symptoms are non-specific and diagnosis is difficult. The intracellular life-cycle of Listeria protects the bacterium from host innate and adaptive immune responses. Antibiotic treatment requires agents able to penetrate, distribute, and remain stable within host cells. Prolonged use of high-dose ampicillin can significantly improve neonatal outcome.
Introduction
Since the 1960s, and following the introduction and widespread use of refrigerators, processed foods, and the extended shelf-life of foods, listeriosis due to Listeria monocytogenes has become more widespread. Although rare in pregnancy, because of the potential for serious feto-maternal consequences, it is important that practicing obstetricians are familiar with the diagnosis, pathogenesis, treatment and pre-
Epidemiology
In 1997, listeriosis was estimated to be responsible for 500 deaths annually in the USA w98x, and in 2000 the prevalence was estimated to be 4 per million population w20x. In Europe, rates vary between 0.1 and 11.3 per million population, and approximately 20% involve neonatal infection w117x. Though no clear seasonal pattern exists, illness in humans tends to present in late summer and early autumn w80, 97x. When the disease occurs in children, up to 54% have no apparent immunocompromising condition w22, 151x.
Listeriosis is mainly a food-borne infection, and sporadic cases as well as epidemics have been linked to contaminated food w18, 41, 84, 86, 130, 144x . Human listeriosis typically occurs sporadically, but occasional nosocomial clusters have been reported w40, 82, 139x. In the USA, routine screening and surveillance often leads to a recall of food products due to concerns with respect to listerial contamination w71x. Since the same serotypes cause disease in humans and animals w123x, it was originally believed that the disease was caused by direct transmission from animals; however, this has only rarely been documented w14x. In sporadic outbreaks, 11% of all food samples retrieved from refrigerators were contaminated and 64% of the refrigerators of infected cases contained at least one contaminated food item w112, 134x. Table  1 demonstrates steps that can be taken by those at risk for listeriosis that help prevent the disease, based on foods known to be associated with infection or past outbreaks.
Microbiology
Although, Hayem (France, 1891) and Henle (Germany, 1893) observed Gram-positive rods in the tissue sections from patients who died of a disease that, in retrospect, was almost certainly listeriosis, Hülphers (Sweden, 1911) appears to be the first to have recorded an encounter with the organism now known as L. monocytogenes w47x. Reflecting the association with liver abscesses and monocytosis in laboratory animals w26, 102x (which is not a feature of disease in Table 1 CDC recommendations for the prevention of listeriosis.
For the general public
• Thoroughly cook raw food from animal sources, such as beef, pork, or poultry • Wash raw vegetables thoroughly before eating • Keep uncooked meats separate from vegetables and from cooked foods and ready-to-eat foods • Avoid unpasteurized (raw) milk or foods made from unpasteurized milk • Wash hands, knives, and cutting boards after the handling of uncooked foods • Consume perishable and ready-to-eat foods as soon as possible For persons at high risk, such as pregnant women and persons with weakened immune systems, in addition to the recommendations listed above
• Do not eat hot dogs, luncheon meats, or deli meats, unless they are reheated until steaming hot • Avoid getting fluid from hot dog packages on other foods, utensils, and food preparation surfaces, and wash hands after handling hot dogs, luncheon meats, and deli meats • Do not eat soft cheeses, such as feta, brie, and camembert; blue-veined cheeses; or Mexican-style cheeses, such as queso blanco, queso fresco, and Panela, unless they have labels that clearly state they are made from pasteurized milk • Do not eat refrigerated pâtés or meat spreads. Canned or shelf-stable pâtés and meat spreads may be eaten.
• Do not eat refrigerated smoked seafood, unless it is contained in a cooked dish, such as a casserole. Refrigerated smoked seafood, such as salmon, trout, whitefish, cod, tuna or mackerel, is most often labeled as ''nova-style,'' ''lox,'' ''kippered,'' ''smoked,'' or ''jerky.'' The fish is found in the refrigerator section or sold at deli counters of grocery stores and delicatessens. Canned or shelf-stable smoked seafood may be eaten. Listeria monocytogenes is a small, facultatively anaerobic, Gram-positive, flagellated, linear motile rod, which is nonspore forming and microscopically difficult to distinguish from commensal Diphtheroids w17, 106x. Therefore, it was initially thought to be of the genus Corynebacterium w79x. For an historical perspective on the microbiology of Listeria, the interested reader is referred to a comprehensive review by Farber and Peterkin w38x.
Listeria grows well in broth, blood agar and most routine culture media w62x. Nevertheless, selective media, enrichment, and subculture may be necessary to avoid false-negatives from overgrowth of Gram-negative organisms from contaminated sites like the vagina and rectum w30, 74, 81x. Human pathogenic species produce a narrow zone of bhemolysis on sheep blood agar w37, 48, 147x, but while suspected to be a virulence factor, the presence of listeriolysin does not correlate with the severity of disease w43, 53, 77, 78, 109, 140x.
Listeria monocytogenes tolerates high and low temperatures as well as high salt concentrations. As a result, it replicates well in soil, dust, water, sewage, manure, silage and animal feeds w1, 39, 76, 156, 157x . Listeria grow at refrigerator temperatures (therefore contaminate refrigerated foods and raw meat), and can be detected in the feces of animals and humans w144x. Although it can survive for many months in soil w156x, pasteurization and most disinfecting agents eliminate the organism w115x. While Listeria can be isolated from stool cultures of 5% of healthy individuals w12, 51, 52, 75, 84, 129, 134x and fecal carriage of Listeria occurs in 1-15% of the population, vaginal carriage is lower w84x. Pathogenic strains have been detected in the gastrointestinal (GI) tract of asymptomatic individuals, including those at risk (such as pregnant women or immunocompromised patients) w75, 81, 137x.
Colonization with Listeria
Exposure to and transient colonization of the GI tract by L. monocytogenes appears to be common, but invasive disease is rare. Using repeated sampling, Listeria can be detected in the feces of nearly 70% of healthy non-pregnant individuals and 44% of pregnant women w74x. Single samples of feces during pregnancy (with careful attention to culture techniques) have a 12% culture positive rate w74x, yet others have reported lower recovery rates of 1.1-3.9% w46, 81x. Pregnancy does not appear to affect the fecal, cervicovaginal or oropharyngeal carriage rate of Listeria, but such carriage has been reported as a possible predisposing factor for perinatal listeriosis w81x. A study of 750 healthy pregnant women reported that 3.9% had a positive rectal culture while only one woman (0.13%) had a positive vaginal culture w84x. Four studies comprising more than 1000 healthy pregnant women overall found positive cervicovaginal cultures of L. monocytogenes to be very rare w64, 81, 84, 116x.
Pathogenesis of infection
Listeria monocytogenes is an intracellular pathogen which, following ingestion of contaminated food, is phagocytosed and internalised in epithelial cells by the interaction between the bacterial surface protein, internalin, and its receptor on the epithelial surface, E-cadherin. The organism is vacuolated by macrophages, polymorphonuclear leucocytes and other plasma cells, and escapes the vacuole through the action of listeriolysin, finally entering the cytoplasm where proliferation occurs w87x. In the cytoplasm, Act A, another virulence factor, induces actin polymerization to form filaments which become a propulsion system for the organism w114x. The organism then migrates to the cell membrane and produces pseudopodia-like structures which extrude from the host cell, are recognized by adjacent cells and phagocytosed, so that the intracellular cycle continues w144x. This cell-to-cell spread accounts for the fact that antibodies, complement and neutrophils have little or no effect in host protection w62, 87, 114, 144x. Since L. monocytogenes can enter the host without disrupting the integrity of the GI tract w144x, it has been suggested that GI symptoms may reflect a non-specific response to a systematic infection. Alternatively, GI symptoms may represent a concurrent illness through other organisms (such as Shigella) in the GI tract, which disrupt mucosal integrity and facilitate invasion of L. monocytogenes w12, 87, 132, 135x. Otherwise, GI symptoms may simply reflect the spectrum of illness of listeriosis itself.
Listeria activates T-cell mediated immunity which, under the influence of cytokines, attracts macrophages that produce inflammatory granulomata where bacteria are destroyed w90x. Memory T-cells provide an acquired resistance to Listeria infection, and this might explain why listeriosis is linked with malignancy, immunosuppressive therapy, AIDS, pregnancy and the neonate. This can also account for the observation that neutropenia and disorders of complement or immunoglobulin synthesis are not associated with excessive prevalence of the disease w8, 13, 32, 68, 90x. Apart from the immune status of the host, other factors which influence whether or not invasive disease occurs include the virulence of the infecting strain and the size of the inoculum w67, 118, 131x. The infective dose is unknown, but is estimated to be between 10 4 and 10 6 organisms/g of ingested product, although this estimate might be lower in groups at risk w60, 100, 128x. The duration of the incubation period is also unknown, but is likely to be about three weeks w112, 134x.
Listeriosis in pregnancy Epidemiology
Listeriosis is 18 times more common in pregnancy (12/ 100,000) than in the non-pregnant population (0.7/100,000) w144x, and 16-27% of all infections with Listeria occur in pregnant women w69, 71, 154x. Sporadic cases of perinatal listeriosis, as well as epidemic cases, have been reported with a prevalence that varies between 8.6 and 17.4/100,000 of live births w144, 148x. The largest reported epidemic occurred in 1985 in Los Angeles, CA, USA. Of 142 reported cases of listeriosis, 65.5% occurred in pregnant women w86x. The source was contaminated Mexican-style cheese made with unpasteurized milk, which is a well-known risk factor for the acquisition of listeriosis. Indeed, Hispanic (compared to nonHispanic) women are at a significantly greater risk of pregnancy-associated listeriosis due to their consumption of food known to be at higher risk of contamination with L. monocytogenes w154x.
Underlying maternal risk factors are uncommon (4.5%), and serious maternal disease is rare when other risk factors are absent w22, 44x. However, one case of maternal meningoencephalitis in a series of 248 cases of Listeria in pregnancy has been reported w94x, as well as a case of maternal listerial endocarditis w63x. In addition, an analysis of mother-infant pairs with Listeria showed that one-third of mothers had Listeria isolated from blood cultures, and nearly half were hospitalized w69x. Listeriosis occurs mainly in the third trimester, perhaps due to deficient cell mediated immunity w14x; yet, cases have been observed at earlier gestational ages w46, 111x. The incidence at lower gestational ages may be underestimated due to reluctance to culture aborted fetal tissue or products of conception.
Clinical features
The presentation of listeriosis during pregnancy includes mild flu-like symptoms w10x. In a series of 191 cases of listeriosis in pregnancy, 32% of women had symptoms of a flu-like illness, 65% had a fever, and other symptoms included backache (21.5%) (which may be mistaken for a urinary tract infection), headache (10.5%), vomiting/diarrhea (7%), muscle pains (4%) and sore throat (4%). Approximately 29% of the women were asymptomatic w105x.
Fetal transmission from maternal listeriosis is not invariable w66x, and discordant infection in utero has been observed in a set of twins w142x. Once the placenta is infected, it becomes a reservoir for re-infection w6x, and placental micro-abscesses may be histologically evident w31, 152x.
Listeriosis during pregnancy carries a poorer prognosis for fetuses who are affected at early gestations w105x as opposed to later gestations, and commonly results in spontaneous abortion or stillbirth w72, 121x. The association with recurrent abortion has been reported in a series of cases in which Listeria was cultured from the cervix w119x, though this has been questioned w4, 91, 92x mainly because of the inability to substantiate the presence of the organism microbiologically w2, 49, 85, 125, 126, 150x. Preterm birth is common w9x, and the highest mortality rate is predictably among infants born at the earliest gestations w94x. Two studies have been reported w94, 105x, one with 222 pregnant women comprising 11 culture-confirmed cases and 211 cases reported in the literature w105x, and the other with 722 pregnant women who were either culture-positive or had clinical suspicion of listeriosis w94x. Spontaneous abortion occurred in 10-20% of cases, approximately 50% delivered preterm, intrauterine fetal death occurred in approximately 11% w94x, 34% demonstrated fetal distress, and 75% developed meconium staining of the amniotic fluid particularly at early gestation w94, 105x.
In another study, tissue from preterm births or spontaneous abortions (which occurred around three to seven days postinfection) tested positive for Listeria in 1.6% of cases w45x.
Of 34 women with a history of recurrent abortions and 87 controls, positive cultures were found in 73.5% and 0%, respectively w119x. Other studies w4, 83, 91, 92x failed to confirm these findings; therefore, routine genital tract culture and treatment are not recommended w138x. Nonetheless, although rare and because of the potentially serious consequences, it is important that practicing obstetricians are familiar with the diagnosis, treatment, and prevention of Listeria infection w124x.
Neonatal listeriosis
While maternal illness ''due to listeriosis'' may be mild, neonatal illness is often severe and may be fatal. Neonatal listeriosis may occur by vertical transmission of L. monocytogenes from mother to fetus, either by inhalation of infected amniotic fluid, transplacentally from the maternal circulation w9x or by ascending colonization from the vagina. Though vaginal colonization is rare, nearly half of asymptomatic mothers of infants born with neonatal listeriosis will have a positive vaginal culture for L. monocytogenes w84x. This observation is consistent with other perinatal infections like group B Streptococcus (GBS). Similar to GBS, Listeria is likely to result from spread to the vagina from the lower GI tract w5, 15, 28x. Furthermore, ascending vaginal colonization is supported by the finding of listerial colonization solely in the firstborn of a set of twins w55x. However, hematogenous spread may be more likely, and documented maternal bacteriuria and in utero fetal infection with positive amniotic fluid cultures prior to labor have been recorded w93x. In addition, nosocomial cross-infection has been reported w36, 133, 54, 115, 116x.
Neonatal listeriosis occurs in approximately 8.6/100,000 of live births w20x, and is one of the most common causes of neonatal meningitis. The clinical manifestations of neonatal listeriosis are similar to GBS, and there is a high mortality rate (20-60%) w2, 86, 94, 105, 136x. One study reported that 68% of newborns whose mothers were diagnosed with listeriosis as a result of positive cultures from placenta, maternal blood or cervix developed neonatal infection; of those 68.2% made a complete recovery, 12.7% developed long-term neurological sequelae, and the infant mortality rate was 24.5% w105x. Like GBS, there are two forms of the disease in the neonate, early-and late-onset, suggesting different modes of transmission (vertical and nosocomial) w150x.
Early-onset
Symptoms of early-onset listeriosis occur at a mean of 36 h after birth w123x. In 50-74% of cases, the mother is likely to have had a flu-like illness with symptoms of fever, headache and myalgia w55, 86, 94, 123x, and isolation of L. monocytogenes from maternal blood or genital tract is common (44-89%) w86, 94x. Neonates with early-onset infection are more frequently born preterm and associated with chorioamnionitis. The fetus presents with clinical features like septicaemia (81-88%), respiratory distress or pneumonia (38%), meningitis (24%) w86, 94x and occasionally disseminated inflammatory granulomata (granulomatosis infantisepticum) w7, 17, 64, 72, 119, 120x, from which pure culture of L. monocytogenes can be obtained w121, 122x. Granulomatosis infantisepticum was reported for the first time in 1893 (at which time, the disease was named pseudotuberculosis) w59x, and is a pathognomonic feature of listeriosis w79x.
Late-onset
In contrast, late-onset neonatal listeriosis (commonly due to serotype 4b) w3x, tends to occur between five days and two or more weeks post-partum, typically in term neonates w2, 94x. Also typical of these cases is that the neonate is born to asymptomatic mothers with failure to isolate L. monocytogenes from maternal cultures w86, 94x. The clinical features may be non-specific, but septicaemia (17-95%) and meningitis (67-93%) are common w115, 141x. Neonatal listeriosis is one of the few congenital infections in which antibiotic therapy can improve outcome w23, 42, 105, 159x.
Diagnosis
Diagnosis of maternal listerial infection may be difficult due to the lack of GI symptoms normally associated with foodborne pathogens and non-specific symptoms of malaise and influenza. Hematologically, a leucocytosis occurs rather than a monocytosis as the species name suggests. On wet mount microscopy, the organisms may be seen in characteristic ''tumbling'' motion, or may be evident on Gram stain, particularly if done on neonatal meconium before polymicrobial colonisation of the gut occurs. Gram stain is only useful in a minority of cases because, as an intracellular organism, it is easily missed and microscopically resembles many other bacteria commonly found in the vagina. This being the case, warning the microbiological microscopist of the possibility of listerial infection may improve the diagnosis using Gram stain w71x. Isolation is usually by culture from blood (maternal or neonatal), neonatal cerebrospinal fluid (CSF), amniotic fluid, the uterine cavity or the placenta w69, 105x. The organism grows well from blood or CSF without the need for enrichment or selective media, and post-partum, histological evidence of micro-abscesses in the placenta can be found w31x.
Using the ability of Listeria to grow at extreme temperatures, ''cold enrichment'' involving culture at 48C (which discourages the growth of other organisms) may help identification w50x. However, this is time-consuming and not as accurate as selective media to isolate the organism from contaminated sites, such as food or stools, which contain multiple species of Listeria w57x. Rapid detection, at least to the genus level, is possible using monoclonal antibody tests or DNA hybridization w25, 29, 44, 143, 155x. Serological testing for anti-listeriolysin may assist in diagnosing both invasive and non-invasive listeriosis w11, 24, 35x, and identification to the species level is possible using specific primers for L. monocytogenes. Recently, a 16S rDNA assay with specific primers for the four major food-borne pathogens (Escheri-chia coli, Salmonella, Campylobacter and Listeria) has been successfully tested w146x.
Prevention of listeriosis
In the USA, Listeria became nationally notifiable in 1999, and every occurrence should be reported to local health departments. Currently, no vaccine for Listeria exists. Most cases of listeriosis are sporadic and not associated with an outbreak w105x. Most sporadic cases, as well as all large outbreaks, are due to manufactured foods w16x, particularly ready-to-eat meats (especially hot dogs w96x), w70, 97, 105, 138, 144x, and dairy products such as soft cheeses w21, 86, 141, 148x. Most dairy-associated outbreaks are due to inadequate pasteurization, unpasteurized dairy products w86x, or contamination post-pasteurization w21x.
The Centers for Disease Control and Prevention (CDC) have issued general recommendations for the prevention of listeriosis (Table 1 ). CDC recommendations state that all deli meats can be consumed safely if reheated until steaming hot. Prevention or avoidance of cross-contamination is an important preventative measure, and all utensils and surfaces should be cleaned after preparing meat dishes or cutting unprepared foods. Following the 1985 listeriosis outbreak w86x, the CDC began monitoring dairy products and sporadic cases of listeriosis, including the voluntary recall of products and has maintained a zero tolerance policy for contaminated ready to eat products. This has resulted in a 44% reduction in the incidence of perinatal listeriosis in the USA (from 17.4/100,000 to 8.6/100,000 live births) w148x.
Patient awareness
Despite the CDC recommendations, in a US national survey of 403 pregnant women, only 18% were familiar with listeriosis and -30% knew that it could be prevented by avoiding delicatessen meats, soft cheeses and unpasteurized dairy products. In focus groups, many had heard of E. coli and Salmonella, but few knew that pregnancy increased the risk for development of listeriosis, none had made any change to their food-handling habits, and all had continued to eat hot dogs and delicatessen meats during pregnancy w108x. Both commercially and in the home, individuals at low risk for listeriosis (who may therefore not be aware of the precautions needed to reduce the risk of listeriosis) often prepare food for pregnant women who are at higher risk. For these individuals, multimedia education has been recommended w19x.
Treatment of listeriosis
Treatment of listeriosis in pregnancy requires collaboration with an infectious diseases specialist, and should also involve pediatricians. Irrespective of the gestational age at which infection occurs in pregnancy, treatment is directed toward improving neonatal outcome. Early recognition and intervention are associated with improved outcome, and some physicians have advocated the use of antibiotics for the suspicion of Listeria infection for high-risk cases after samples for culture have been obtained w138x.
In contrast to other causes of chorioamnionitis in which induction of labor is the standard of care w138x, treatment of maternal listeriosis in pregnancy and delay of delivery can result in the birth of a healthy infant at term w23, 42, 66, 73, 105, 159x . Amniotic fluid cultures have been observed to change from positive to negative with appropriate antibiotic therapy w27x. Ideally, successful reports of in utero therapy should be accompanied by documentation of resolution by demonstrating negative amniotic fluid cultures.
Treatment challenges
No randomized controlled trials to assess type of antibiotic or duration of treatment have been performed. Therapeutic considerations include the fact that: 1) host susceptibility is linked to the atypical onset of the disease. The non-specific nature of the normal symptomatology may also make diagnosis and treatment difficult; and 2) the intracellular nature of the organism presents therapeutic challenges. Both of these factors may delay diagnosis and treatment. Bacteriostatic concentrations in vivo may be insufficient to be effective intracellularly. As a result, treatment recommendations are based mainly upon in vitro susceptibility testing or animal-model experimentation or are experience-based, following trials with small numbers of historical controls rather than being based on a foundation of robust medical evidence w149x.
Antibiotics
The antibiotic of choice should penetrate host cells, distribute within the cells and remain stable in the intracellular environment w115, 138, 144x. As a result of these unusual antibiotic requirements, antibiotics may be ineffective in up to 70% of listeriosis cases w61x. Most of the experience of treating L. monoctogenes is with the use of ampicillin, penicillin and amoxicillin w149x, and to date, no bacterial resistance to penicillin has been detected w62x. In vitro, L. monocytogenes has a wide range of antibiotic sensitivities but is resistant to cephalosporins, clindamycin and chloramphenicol w33, 105x. Chloramphenicol should not be used because of unacceptable rates of failure and relapse w21, 68, 87x, and quinolones do not have adequate in vitro activity w34x. Cephalosporins are ineffective against Listeria because they do not bind to bacterial penicillin-bound protein-3 (PBP3) w144, 153x.
Though resistance to ampicillin has been reported w89x, it is preferred over penicillin w10, 105x. Listeria monocytogenes responds poorly to bacteriostatic antibiotics due to the intracellular nature of the pathogen, but ampicillin provides good host cell penetration without any significant change in pH or concentration which might compromise efficiency. Ampicillin also crosses the placenta in adequate amounts and binds to PBP3, causing bacterial death w62x. Gentamicin and tobramycin have been reported to have greater in vitro activity than streptomycin, kanamycin and amikacin w3, 101, 127x. Listerial resistance to vancomycin is rare w62x, and its use (though limited) has been employed in endocarditis, as well as in listerial meningitis (in which cerebral intraventricular injections were administered) w104x.
Synergy of ampicillin with gentamicin is claimed, but this has only been demonstrated in vitro w21, 33, 101, 127, 144x. Nevertheless, these two antibiotics are often used in combination in cases of meningitis despite concerns with respect to toxicity w149x. In patients with an allergy to ampicillin and/or gentamicin, erythromycin may be used w149x, but transplacental passage of erythromycin provides sub-therapeutic concentrations in both amniotic fluid and fetal serum w58x. Alternatively, the combination of trimethoprim and sulfamethoxazole (which is bactericidal and achieves good serum and CSF concentrations) may be used w18, 33, 54, 71, 88, 99, 106, 144, 145, 158x . However, there are concerns regarding the use of sulfonamides due to sulfur allergy and the risk of kernicterus (possible displacement of bilirubin from albumin) from use immediately prior to delivery. There are also concerns about possible teratogenic effects, such as neural tube defects due to the folate antagonism of trimethoprim during pregnancy, as well as hemolytic anemia in male infants due to glucose-6-phosphate deficiency. The preference for ampicillin over other options is such that it has been proposed to test sensitivity for suspected allergy before recourse to alternative therapy w71x.
During pregnancy, the current recommendation for first line therapy is IV ampicillin G6 g/day w149x and erythromycin 4 g/day as second line IV. The duration for both regimes is 14 days, though the length of course may be longer in different clinical syndromes w44x and if the pregnant woman is immunosuppressed w71, 149x.
Conclusion
Listeria monocytogenes is an unusual pathogen due to the intracellular nature of its life cycle, which may explain the ready ease of transplacental passage. With an incidence of 12/100,000 pregnancies, listeriosis in pregnancy is still 18 times more common in pregnant women than in the general population. Pregnant women with co-morbidities are at increased risk due to compromised cell-mediated immunity. Maternal illness is usually mild, but neonatal disease carries a 20-30% mortality rate (although fetal and neonatal mortality are potentially preventable with early diagnosis and intervention). Ready-to-eat meats and dairy products made with unpasteurized milk should be avoided, and care should be taken to prevent cross contamination of foods by ensuring that preparation and cooking utensils and food preparation surfaces are clean. High-dose ampicillin (G6 g/day) for a prolonged period of 14 days is recommended for treatment in pregnancy. 
